EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

B cell dysregulation during acute COVID-19 is transient

Suvi T Jokiranta, Anh Nguyen Ngoc, Xiaobo Huang, Kirsten Nowlan, Leo Hannolainen, Lari Pyöriä, Pirkka T Pekkarinen, Pia Dürnsteiner, Tinja Lääveri, Nelli Heikkilä, Santtu Heinonen, Sini M Laakso und 6 weitere

Immunology Letters · 2026

DOI: 10.1016/j.imlet.2025.107086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology Letters, 2026. Verfasst von Suvi T Jokiranta und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program,…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, B-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Medical Foundation, Biomedicum, The Paulo Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: COVID-19 is still a significant health concern worldwide. B cell responses to COVID-19 have been extensively studied in acute severe disease, but less so during extended follow-up or mild disease. Persisting immunological changes together with herpesvirus reactivations during acute COVID-19 have been suggested as contributing factors for post-acute sequelae of COVID-19 (PASC). Here, we evaluated the natural kinetics of B cell subpopulations together with serological markers of increased B cell activity during acute COVID-19 and long-term follow-up. We also measured human herpesvirus reactivations during acute COVID-19. METHODS: We collected plasma and peripheral blood mononuclear cell samples from 120 SARS-CoV-2 positive patients (outpatients = 56, inpatients = 64) at up to five timepoints during acute disease and recovery (up to 460 days since symptom onset, dsso). We determined circulating B cell and Th cell subpopulations using flow cytometry, and measured free light chains, in addition to Epstein-Barr virus (EBV) serology, and herpesvirus qPCR from the plasma samples. The presence of anosmia as a proxy for PASC was self-reported at 3-12 months post-COVID. RESULTS: All changes in B cell subpopulation proportions normalized within 200 dsso. Likewise, the acute alterations observed in circulating T follicular helper and T follicular regulatory cell proportions stabilized soon after. Free light chains were high in acute COVID-19, especially in inpatients, but normalized during follow-up. EBV and human herpesvirus 6B (HHV-6B) reactivations were significantly more common in inpatients than outpatients, with reactivation in 47 and 19 % of inpatients and 4.3 and 0 % of outpatients respectively. Anosmia was not significantly associated with any herpesvirus reactivation. CONCLUSIONS: The circulating B cell and Th cell subpopulations experience transitional changes during SARS-CoV-2 infection, but these changes recover in follow-up. EBV and HHV-6B reactivations are common in inpatients, but they are not associated with persisting anosmia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2B-LymphocytesHumansMaleMiddle AgedFemaleAdultAgedHerpesvirus 4, HumanAnosmiaB-Lymphocyte SubsetsVirus Activation

Stichwörter der Autor:innen

B cellsCOVID-19Epstein-Barr virusFree light chainsHerpesvirus reactivationHuman herpesvirus 6SARS-CoV-2T follicular helper cellsT follicular regulatory cells

Autor:innen und Institutionen

  • Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Elect…
  • Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Divis…
  • Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Aalto University, Department of Computer Science, School of Science, Espoo, Finland.

Förderung

  • Finnish Medical Foundation
  • Biomedicum
  • The Paulo Foundation
  • Finnish Cultural Foundation
  • Orion Research Fundation

Zitieren

APA

Jokiranta, S. T., Nguyen Ngoc, A., Huang, X., Nowlan, K., Hannolainen, L., Pyöriä, L., Pekkarinen, P. T., Dürnsteiner, P., Lääveri, T., Heikkilä, N., Heinonen, S., Laakso, S. M., Kantele, A., Vapalahti, O., Strandin, T., Hepojoki, J., Perdomo, M. F., & Kekäläinen, E. (2026). B cell dysregulation during acute COVID-19 is transient. Immunology Letters. https://doi.org/10.1016/j.imlet.2025.107086

Vancouver

Jokiranta ST, Nguyen Ngoc A, Huang X, Nowlan K, Hannolainen L, Pyöriä L, et al. B cell dysregulation during acute COVID-19 is transient. Immunology Letters. 2026. doi:10.1016/j.imlet.2025.107086

BibTeX
@article{Jokiranta2026,
  author = {Jokiranta, Suvi T and Nguyen Ngoc, Anh and Huang, Xiaobo and Nowlan, Kirsten and Hannolainen, Leo and Pyöriä, Lari and Pekkarinen, Pirkka T and Dürnsteiner, Pia and Lääveri, Tinja and Heikkilä, Nelli and Heinonen, Santtu and Laakso, Sini M and Kantele, Anu and Vapalahti, Olli and Strandin, Tomas and Hepojoki, Jussi and Perdomo, Maria F and Kekäläinen, Eliisa},
  title = {B cell dysregulation during acute COVID-19 is transient},
  journal = {Immunology Letters},
  year = {2026},
  doi = {10.1016/j.imlet.2025.107086}
}
Kostenlos starten →